How to think about stacking AHK-Cu
- AHK-Cu is a copper-carrying tripeptide (copper tripeptide-3) reported predominantly for hair-follicle and skin research, applied topically.
- It is deliberately excluded from this site's per-compound calculator route because injectable use is not its reported route. Reconstitution examples for it should be read as concentration math, not route guidance.
- It carries copper, so combining it with GHK-Cu compounds cumulative copper exposure without adding a mechanism — the clearest class collision in the skin group.
- No controlled trial has studied it combined with anything, and its own human evidence is thin.
Combinations in detail
Hair & skin regenerative stack
AHK-Cu + GHK-Cu- Why it is proposed
- The most-reported pairing: two copper tripeptides framed as complementary, AHK-Cu toward hair follicles and GHK-Cu toward skin matrix remodeling.
- What is reported in practice
- Reported topically for both, which matches both compounds' evidence bases better than injection does.
- Cautions specific to this combination
- Both deliver copper. Systemically this would compound cumulative exposure without adding a mechanism; topically that concern is much reduced, which is part of why the pairing is discussed topically.
Tissue-repair pairing
AHK-Cu + BPC-157 or TB-500- Why it is proposed
- Copper-peptide activity alongside the repair compounds — unrelated mechanisms.
- What is reported in practice
- Reported with AHK-Cu topical and the repair compounds injected.
- Cautions specific to this combination
- Route mismatch between components is the practical issue; no combination data.
What to avoid, and why
- Constructing an injectable AHK-Cu protocol — its reported route is topical, and the calculator deliberately excludes it for that reason.
- Stacking it with GHK-Cu systemically; two copper carriers compound exposure without adding mechanism.
- Reading GHK-Cu's larger evidence base as covering AHK-Cu; they are different molecules with different literatures.
Related reading
Every combination described here is reported practice or mechanism-level reasoning. No controlled trial has studied any of these combinations, and nothing on this page is a personal protocol, a dose recommendation, or medical advice.